Warmuth Markus
Transaction: 07/16/2026
SELL
Change
-9,500
Price
$23.18
Filing
07/17/2026
Type
SELL
Monte Rosa Therapeutics, Inc.
GLUE • Biotechnology
$11.36
— 0.00 (0.00%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$1.15B
Growth
—
Cash Flow
1/5
Trend
Volatile
Evidence
Positive revenue growth · 45.5%Manageable debt level · 0.17Healthy liquidity · 6.12Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 7, 2026, 1:05 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$11.36
Change0.00%
Shares Out101.48M
Market Cap$1.15B
Enterprise Value$569.68M
52W Range4.12 - 25.77
Beta1.56
P/E-7.16
P/S40.13
P/B2.37
P/FCF-16.16
EV/Sales19.83
Price$11.36
Change0.00%
Shares Out101.48M
Market Cap$1.15B
Enterprise Value$569.68M
52W Range4.12 - 25.77
Beta1.56
P/E-7.16
P/S40.13
P/B2.37
P/FCF-16.16
EV/Sales19.83
EV/EBITDA-3.40
EV/FCF-7.99
Earnings Yield-13.98%
FCF Yield-6.19%
Dividend Yield0.00%
Gross Margin93.24%
Oper. Margin-43.83%
Profit Margin-31.23%
Debt/Eq0.17
Current Ratio6.12
Quick Ratio6.12
Target$24.83
Target Upside118.57%
Target Median$25.00
Target Range19.00 - 28.00
Volume1.05M
Avg Volume1.14M
EPS Surprise-0.17
Investment DNA
How strong this company looks for long-term investors
47
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
38/100
Why this score▼
Positive revenue growth · 45.5%Manageable debt level · 0.17Healthy liquidity · 6.12Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 10 analyst votes · 2026-10-20
90/100
Bullish
Bullish
8
Hold
2
Bearish
0
Price Target
2026-08-07
Low
$25.00
Mean
$29.00
Median
$27.00
High
$35.00
Insider Transactions
Recent executive and insider activity
Champoux Jennifer
Transaction: 07/15/2026
SELL
Change
-4,351
Price
$3.98
Filing
07/16/2026
Type
SELL
Champoux Jennifer
Transaction: 07/15/2026
SELL
Change
-4,351
Price
$23.38
Filing
07/16/2026
Type
SELL
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Warmuth Markus | SELL | -9,500 | $23.18 | 07/16/2026 | 07/17/2026 |
| Champoux Jennifer | SELL | -4,351 | $3.98 | 07/15/2026 | 07/16/2026 |
| Champoux Jennifer | SELL | -4,351 | $23.38 | 07/15/2026 | 07/16/2026 |
| Townson Sharon | SELL | -400 | $24.13 | 07/06/2026 | 07/07/2026 |
| Townson Sharon | SELL | -6,000 | $6.14 | 07/06/2026 | 07/07/2026 |
| Behbahani Ali | SELL | -15,000 | Not reported | 07/01/2026 | 07/06/2026 |
| Janku Filip | SELL | -5,407 | $24.50 | 06/30/2026 | 07/01/2026 |
| Janku Filip | SELL | -5,407 | $13.41 | 06/30/2026 | 07/01/2026 |
| Manning Anthony M. | SELL | -10,000 | $4.16 | 06/29/2026 | 06/30/2026 |
| Manning Anthony M. | SELL | -10,000 | $23.11 | 06/29/2026 | 06/30/2026 |
| Janku Filip | SELL | -6,000 | $7.56 | 06/29/2026 | 06/30/2026 |
| Janku Filip | SELL | -6,000 | $22.95 | 06/29/2026 | 06/30/2026 |
| Janku Filip | SELL | -30,000 | $7.56 | 06/24/2026 | 06/25/2026 |
| Janku Filip | SELL | -30,000 | $21.42 | 06/24/2026 | 06/25/2026 |
| Townson Sharon | SELL | -3,000 | $20.00 | 06/23/2026 | 06/25/2026 |
| Townson Sharon | SELL | -3,000 | $6.14 | 06/23/2026 | 06/25/2026 |
| Champoux Jennifer | SELL | -2,175 | $3.98 | 06/23/2026 | 06/25/2026 |
| Champoux Jennifer | SELL | -2,175 | $20.00 | 06/23/2026 | 06/25/2026 |
| Janku Filip | SELL | -11,845 | $20.22 | 06/23/2026 | 06/25/2026 |
| Janku Filip | SELL | -6,000 | $7.56 | 06/23/2026 | 06/25/2026 |